HealthStream Inc. (HSTM) Jumps 11.41% on February 17

Equities Staff |

HealthStream Inc. (HSTM) was among the biggest gainers on the Russell 2000 for Wednesday February 17 as the stock popped 11.41% to $22.36, representing a gain of $2.29 per share. Some 439,749 shares traded hands on 2,778 trades, compared with an average daily volume of 113,078 shares out of a total float of 31.65 million. The stock opened at $21.60 and traded with an intraday range of $24.14 to $21.60.

After today's gains, HealthStream Inc. reached a market cap of $707.6 million. HealthStream Inc. has had a trading range between $32.41 and $17.80 over the last year, and it had a 50-day SMA of $21.28 and a 200-day SMA of $25.15.

The stock has a P/E Ratio of 62.7.

HealthStream Inc provides SaaS-based workforce development solutions and research/patient experience solutions for healthcare organizations. It provides HealthStream Workforce Development Solutions & HealthStream Research/Patient Experience Solutions.

HealthStream Inc. is based out of Nashville, TN and has some 787 employees. Its CEO is Robert A. Frist.

For a complete fundamental analysis analysis of HealthStream Inc., check out’s Stock Valuation Analysis report for HSTM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…

Mesa-Marshall 2 Well Project

MESA Resources ("MESA") is sponsoring the development of the two well direct drilling project -- "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development of…